The Lancet Series on HIV Prevention  TUSS02

Organiser:
Type:
Special Session Back
Venue: SR 9 (950)
Interpretation: None
Time: 12:45 - 14:15, 05.08.2008
Code: TUSS02
Co-Chairs: Helene Gayle, United States
Richard Horton, United Kingdom (Chairperson)


Click here to see a webcast of this session on kaisernetwork.org

Twenty five years into the global HIV/AIDS response, it is widely acknowledged that we cannot treat our way out of the HIV pandemic. The Lancet series consists of six reviews on the challenges of current and future needs for global HIV prevention. It includes the evidence for biomedical interventions, how to improve behavioural approaches, addressing and understanding structural approaches, how to make programmes work and scale them up on the ground. The papers draw on the successes and failures in HIV prevention to date and conclude with a call to action in forming and sustaining a new prevention movement that will push prevention efforts beyond the current levels.



Presentations in this session:

12:45
TUSS0201
The history and challenge of HIV prevention
Jeffrey O'Malley, United States


13:00
TUSS0202
Powerpoint (457 KB)
Biomedical interventions to prevent HIV: Evidence, challenges and the way forward
Nancy Padian, United States


13:15
TUSS0203
Powerpoint (579 KB)
Behavioral strategies to reduce HIV transmission: How to make them work better
Thomas Coates, United States


13:30
TUSS0204
Powerpoint (32 KB)
Understanding and addressing structural factors in HIV prevention
Jessica Ogden, United States


13:45
TUSS0205
Powerpoint (821 KB)
Making HIV prevention programmes work
Stefano M Bertozzi, Mexico


14:00
TUSS0206
Powerpoint (5.14 MB)
Coming to terms with complexity: A call to action for HIV prevention
Peter Piot, Belgium








Rapporteur report

Track E report by Stefan Baral


HIV prevention strategies are most effective when multifaceted and focused on mitigating the economic, political, and social foundations of HIV epidemics rather than solely the individual level determinants of this disease.  These structural risk factors contextualize, and are intimately linked, to the individual risk of HIV infection.  HIV interventions should include a structural approach, even though the benefit of these approaches is difficult to demonstrate in either epidemiologic or evaluative research. 

 

We have known for over a dozen years that efficacious suppression of HIV replication requires multiple antiretroviral medications.  Treatment with a single medication is generally a failed strategy, and in the long term will likely do more harm than good.  This may hold true for the application of single prevention strategies, which has been the norm to date.  There is consensus that there exists no single magic prevention bullet and all possible combinations of biomedical and behavioural interventions need to be evaluated with different combinations likely appropriate for different populations in different regions.

 

While there may be some positive news about advances in prevention, the reality is that we continue to fail at preventing HIV infection.  And even when programs do prevent HIV infection, rarely is the effectiveness adequately evaluated.  There are important lessons to be learned from the private sector in the area of monitoring and evaluation that will maximize the efficiency of prevention programming, which should translate into more infections averted and lives saved.

 

Peter Piot: “A failure of confidence now in our collective capacity to deliver full-scale and effective HIV prevention would be devastating.”

 

As a note, immediately after delivering this quote and showing a slide which called for political courage to adddress prevention wioth sex workers, MSM and drug users, Dr. Piot was asked about the lack of UNAIDS leadership and guidance on HIV prevention programming among sex workers.  Unfortunately, the question was ignored and this notable issue remains unresolved.

 




   

   

    The organizers reserve the right to amend the programme.


Copyright Notice © IAS Disclaimer